Investor Slashes Million From Zymeworks as Stock Jumps 60%
A large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
A clear look at the stablecoins that outperformed peers this year, with insights into drivers and risk considerations for future allocations.
26,211 articlesA large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
Thirty-five donor families pledged $1.03 billion to multi-year initiatives across the U.S. and beyond, a landmark dis...
A high-profile PR moment becomes a money lesson. This article breaks down how apology politics affect fame and fortun...
Walmart’s top HR executive is calling for a nationwide push to train workers in AI, arguing the U.S. risk of falling ...
Palantir rides the AI hype as demand grows, but valuation concerns and fears of the AI gold rush eroding its edge kee...
Opendoor launches a beta financing program offering below-market mortgages on homes listed on its platform, aiming to...
Oil prices jump as geopolitical tensions intensify, setting up a potential upside for select energy stocks. Three nam...
Three consumer-facing stocks — Planet Fitness, Brown-Forman, and Campbell’s — moved on earnings, tariffs, and margin ...
Three utility ETFs are posting eye-catching gains as data-center demand grows, underscoring a new growth era for the ...
Leveraged Ether funds like ETHU are amplifying Ethereum moves even as crypto volatility spikes and regulators weigh a...
A fresh examination of the innovations powering U.S. military dominance and how investors are pricing defense names i...
Eli Lilly unveiled a direct-to-employer program for Zepbound, aiming to accelerate GLP-1 adoption and expand market s...